Samarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer, Prostate Cancer, and Metastatic Cancer. It is grouped under the following drug class(es): Radiopharmaceuticals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 153Sm radioisotope and 153Sm. Its PubChem CID is 114941.
Samarium Sm-153
| CAS No | 15766-00-4 |
|---|---|
| Molecular Formula | Sm |
| Molecular Weight | 152.92210 g/mol |
| Synonyms | samarium-153 |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Samarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer, Prostate Cancer, and Metastatic Cancer. It is grouped under the following drug class(es): Radiopharmaceuticals.
The listed CAS number is 15766-00-4.
The listed molecular formula is Sm.
The listed molecular weight is 152.92210 g/mol.
samarium-153.
The source lists 153Sm radioisotope and 153Sm.